Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Rayonier Inc. (Symbol: RYN) were yielding above the 5% mark based on its quarterly dividend (annualized to $1.09), with the stock changing hands as low as $21.30 on the day. Dividen
Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Rayonier Inc. (Symbol: RYN) were yielding above the 5% mark based on its quarterly dividend (annualized to $1.09), with the stock changing hands as low as $21.30 on the day. Dividen
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in CAVA Group Inc (Symbol: CAVA), where a total volume of 15,355 contracts has been traded thus far today, a contract volume which is representative of approximatel
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in CAVA Group Inc (Symbol: CAVA), where a total volume of 15,355 contracts has been traded thus far today, a contract volume which is representative of approximatel
Former Labour grandee’s arrest over his links to Epstein came after Met police informed he was preparing to fly to British Virgin Islands Peter Mandelson condemned the police for his arrest on Monday and claimed he was only taken into custody because detectives had wrongly believed he was about to flee the country. In a remarkable rebuke to the Metropolitan police, lawyers for the former peer chal...
Former Labour grandee’s arrest over his links to Epstein came after Met police informed he was preparing to fly to British Virgin Islands Peter Mandelson condemned the police for his arrest on Monday and claimed he was only taken into custody because detectives had wrongly believed he was about to flee the country. In a remarkable rebuke to the Metropolitan police, lawyers for the former peer challenged the force to provide the evidence to justify their actions, insisting it was prompted by a “baseless” suggestion that he was planning to move abroad. Continue reading...
Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Albany International Corp (Symbol: AIN) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.12), with the stock changing hands as low as $52.45 on the d
Looking at the universe of stocks we cover at Dividend Channel, in trading on Tuesday, shares of Albany International Corp (Symbol: AIN) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.12), with the stock changing hands as low as $52.45 on the d
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Constellation Energy Corp (Symbol: CEG), where a total volume of 23,918 contracts has been traded thus far today, a contract volume which is representative of ap
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Constellation Energy Corp (Symbol: CEG), where a total volume of 23,918 contracts has been traded thus far today, a contract volume which is representative of ap
Getty Images Whenever I rate a company a "Strong Buy," I am making the claim that the stock should experience upside that far exceeds what the market should enjoy over the same window of time. Although I do not have a perfect track record, my track record is pretty good. Take, for instance, the case of BorgWarner ( BWA ), a rather interesting prospect that provides offerings to automotive OEM firm...
Getty Images Whenever I rate a company a "Strong Buy," I am making the claim that the stock should experience upside that far exceeds what the market should enjoy over the same window of time. Although I do not have a perfect track record, my track record is pretty good. Take, for instance, the case of BorgWarner ( BWA ), a rather interesting prospect that provides offerings to automotive OEM firms across the globe. Of course, it does other things as well. This includes providing products that are used in commercial vehicles like trucks and buses, agricultural and construction machinery, and even marine vessels. In my article about the company, published in December 2021, I called it a "Strong Buy." The stock was attractively priced, and I remained optimistic about the kind of growth that it would experience because of electric vehicles. Since then, the firm has done remarkably well. Even though revenue has been more or less flat and profitability has actually declined, cash flows for the business have jumped. This has pushed the stock up 66.2% at a time when the S&P 500 is up only 47.6%. Looking at the data today, I see the shares still remain attractive. This is especially true if we take management's guidance for 2026 as gospel. Relative to other similar enterprises, however, it is true that the stock is priced a bit on the higher end of the spectrum. But honestly, even with that factored in, I believe that the picture is quite appealing right now. It's not as appealing, of course, as it was back then. But that gap is largely because of changes in valuation. I am also a bit concerned about the economy more broadly and the impact that changes could have on the business. Because of this, I think that downgrading it to a very solid "Buy" candidate is the right move. I’m putting this into a lower gear Author's Compilation - SEC EDGAR Data Over the last few years , the financial picture for BorgWarner has been undeniably mixed. Revenue, for instance, dropped from $14....
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Invesco Ltd (Symbol: IVZ), where a total of 45,506 contracts have traded so far, representing approximately 4.6 million underlying shares. That amounts to about 66.2% of
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Invesco Ltd (Symbol: IVZ), where a total of 45,506 contracts have traded so far, representing approximately 4.6 million underlying shares. That amounts to about 66.2% of
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Brighthouse Financial Inc (Symbol: BHF), where a total of 8,669 contracts have traded so far, representing approximately 866,900 underlying shares. That amounts to about
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Brighthouse Financial Inc (Symbol: BHF), where a total of 8,669 contracts have traded so far, representing approximately 866,900 underlying shares. That amounts to about
Iran Strikes Covert Missile Deal With Moscow In Backchannel Rearmament Iran is squarely in the Trump administration's crosshairs, and both Russia and China are to some degree coming to Tehran's aid with some significant arms deals meant to potentially stave off future attack. Most significantly, the Financial Times is reporting that Russia will supply the Iranians with thousands of advanced should...
Iran Strikes Covert Missile Deal With Moscow In Backchannel Rearmament Iran is squarely in the Trump administration's crosshairs, and both Russia and China are to some degree coming to Tehran's aid with some significant arms deals meant to potentially stave off future attack. Most significantly, the Financial Times is reporting that Russia will supply the Iranians with thousands of advanced shoulder-fired missiles in a deal worth 500 million Euros. via Reuters It's said to be part of a broader effort to rebuild Iran's air defenses, which were heavily destroyed and retarded by Israeli-US airstrikes in the last June war. Iran is also greatly limited given years of US-led sanctions targeting its defense and industrial sectors. Though only coming to light this past weekend, the agreement was inked in Moscow in December, and commits Russia to deliver 500 "Verba" launch units and 2,500 "9M336" missiles over three years . FT says it reviewed leaked Russian documents the UK publication obtained, which revealed the secretive deal for the Russian anti-air defenses. The agreement was reportedly negotiated between Russia’s state arms exporter Rosoboronexport and the Moscow representative of Iran's Ministry of Defense and Armed Forces Logistics (MODAFL), with for example the the 9M336 missiles going for €170,000 per unit. As for the Verba systems, for Moscow they represent a relatively low-cost way to shore up Iran's air defenses, bolstering Tehran's deterrent posture without meaningfully draining Russia's own missile inventories , badly needed for operations in Ukraine and as readiness for some potential future engagement with NATO. Graphic News: the Verba 9K336 MANPADS Last week, Russian naval power was on rare display near Iran, cooperating in planned joint naval drills with the Iranian Navy and IRGC units, in a bit of muscle-flexing as the Pentagon builds up its forces in the Mideast region. If the US were to launch a surprise attack on Iran, it remains unlikely that either ...
Nadzeya Haroshka/iStock via Getty Images Overview My last look at Iovance Biotherapeutics, Inc. ( IOVA ), was last November. This is a company I’ve followed since 2018. Despite the promise of AMTAGVI (lifileucel) in unresectable or metastatic melanoma, I’ve become increasingly cautious in IOVA due to high costs and complex manufacturing. Seeking Alpha Following its Q3 2025 earnings report, I thoug...
Nadzeya Haroshka/iStock via Getty Images Overview My last look at Iovance Biotherapeutics, Inc. ( IOVA ), was last November. This is a company I’ve followed since 2018. Despite the promise of AMTAGVI (lifileucel) in unresectable or metastatic melanoma, I’ve become increasingly cautious in IOVA due to high costs and complex manufacturing. Seeking Alpha Following its Q3 2025 earnings report, I thought the company was still in a “show me” phase. I was particularly interested in Q3 revenue—which came in at $68 million—and gross margin—which improved to 43% (excluding D&A). I wanted to see “two consecutive quarters of ≥$75-$85 million revenue and ≥35% gross margin excluding D&A” before becoming bullish on its stock. On Tuesday, Iovance released its Q4/FY25 results , prompting me to take another look. Earnings Iovance’s Q4 results do show continued improvement. Q4 revenue was ~$87 million—$65 million from AMTAGVI and $22 million from PROLEUKIN. Gross margin, excluding D&A, bumped up to 50%. Iovance ended the year with $303 million in cash—which is expected to fund operations “into the third quarter of 2027.” Iovance did not cite a 2026 guide but plans to provide one " in the very near future ." Operationally, manufacturing turnaround improved to 32 days or less—which is pretty close to my one-month target. This is an important metric, as AMTAGVI’s target population is quite sick and doesn’t have long to wait. According to management, while Q4 featured typical stocking patterns—related to PROLEUKIN—total revenue was driven by actual demand for AMTAGVI. Iovance is pushing for earlier-line use, but this is probably going to be met with a lot of pushback given manufacturing and administration complexities. PROLEUKIN remains a steady contributor whose performance is directly tied to AMTAGIV’s. Recall that PROLEUKIN is given during the AMTAGVI administration process. But, make no mistake about it, Iovance’s prospects fall squarely on AMTAGVI’s performance. AMTAGVI Model When mo...
Century secures win against Pakistan in T20 World Cup Brook: ‘It’s nice to see some rewards for my hard work’ Sometimes Harry Brook makes everything look easy but some of his recent experiences have been anything but painless, and after scoring a sublime century to steer his team into the World Cup semi-finals England’s white-ball captain described his past few months as “probably the hardest of m...
Century secures win against Pakistan in T20 World Cup Brook: ‘It’s nice to see some rewards for my hard work’ Sometimes Harry Brook makes everything look easy but some of his recent experiences have been anything but painless, and after scoring a sublime century to steer his team into the World Cup semi-finals England’s white-ball captain described his past few months as “probably the hardest of my life”. Brook endured a disappointing Ashes, scoring just two half-centuries and averaging 39.77, his second-worst in a Test series in which he has played more than a single innings. It was towards the end of his time in Australia that it was revealed he had got in to a drunken altercation with a nightclub bouncer in Wellington on the eve of the final fixture of his first overseas tour as an international captain, a controversy which has dogged him since. Continue reading...
The rapper, who also serves as the official "hype man" for multiple U.S. Olympic teams, invited the female hockey players to Las Vegas for a "real celebration." (Image credit: Andrew Milligan)
The rapper, who also serves as the official "hype man" for multiple U.S. Olympic teams, invited the female hockey players to Las Vegas for a "real celebration." (Image credit: Andrew Milligan)
Shares of natural gas-focused midstream company Oneok (NYSE: OKE) fell on Tuesday, falling as much as 7% before recovering to a 4.9% decline as of 3:09 p.m. EDT. Oneok reported earnings last night, and while the company actually beat Wall Street's expectations for the fourth quarter, its 2026 guidance left investors wanting. In the fourth quarter, Oneok reported revenue of $9.07 billion and adjust...
Shares of natural gas-focused midstream company Oneok (NYSE: OKE) fell on Tuesday, falling as much as 7% before recovering to a 4.9% decline as of 3:09 p.m. EDT. Oneok reported earnings last night, and while the company actually beat Wall Street's expectations for the fourth quarter, its 2026 guidance left investors wanting. In the fourth quarter, Oneok reported revenue of $9.07 billion and adjusted ( non-GAAP ) earnings per share of $1.55. While the adjusted EPS figure actually declined slightly in the year-ago quarter, the decline was partly due to adverse winter weather that caused plant delays. Both of those numbers beat analyst expectations. Continue reading
SambaNova Systems said on Tuesday it has raised $350 million in a new funding round and struck a partnership with Intel as it seeks to capitalise on surging demand for inference chips used in artificial intelligence applications. Inference chips, which run AI models and power real-time decisions, have attracted intense investor interest following a wave of dealmaking around rivals to Nvidia, as...
SambaNova Systems said on Tuesday it has raised $350 million in a new funding round and struck a partnership with Intel as it seeks to capitalise on surging demand for inference chips used in artificial intelligence applications. Inference chips, which run AI models and power real-time decisions, have attracted intense investor interest following a wave of dealmaking around rivals to Nvidia, as AI companies seek faster and more efficient hardware. Private equity firm Vista Equity Partners and Cambium Capital led the round, which also included Intel's investment arm, Intel Capital, SambaNova said on Tuesday, confirming a Reuters exclusive reported earlier this month.